{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:22:57Z","timestamp":1790774577085,"version":"4.1.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"King Saud University, Riyadh, Saudi Arabia.","award":["RSPD2024R745"],"award-info":[{"award-number":["RSPD2024R745"]}]},{"name":"King Saud University, Riyadh, Saudi Arabia.","award":["RSPD2024R745"],"award-info":[{"award-number":["RSPD2024R745"]}]},{"name":"King Saud University, Riyadh, Saudi Arabia.","award":["RSPD2024R745"],"award-info":[{"award-number":["RSPD2024R745"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00210-025-03899-1","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T02:57:19Z","timestamp":1740193039000},"page":"10379-10398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["3-Acetyl-11-keto-\u03b2-boswellic acid (AKBA) induced antiproliferative effect by suppressing Notch signaling pathway and synergistic interaction with cisplatin against prostate cancer cells"],"prefix":"10.1007","volume":"398","author":[{"given":"Mahima","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah M.","family":"Elgorban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islem","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling Shing","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Sajid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan Ahmad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"issue":"02","key":"3899_CR1","first-page":"406","volume":"1","author":"EZ Abdelaziz","year":"2016","unstructured":"Abdelaziz EZ, AMS H BA, Bayomy NA, Rabat AE, Fawzy MS (2016) Potential anti-angiogenic effect of a combination of boswellic acids and cisplatin against chemically-induced colon cancer in mice. J Chem Biol Ther 1(02):406\u20132572","journal-title":"J Chem Biol Ther"},{"issue":"5","key":"3899_CR2","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-06-2269","volume":"13","author":"VM Adhami","year":"2007","unstructured":"Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H (2007) Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res 13(5):1611\u20131619","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3899_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s43141-023-00529-2","volume":"21","author":"SA Ahmed","year":"2023","unstructured":"Ahmed SA, Al-Shanon AF, Al-Saffar AZ, Tawang A, Al-Obaidi JR (2023) Antiproliferative and cell cycle arrest potentials of 3-O-acetyl-11-keto-\u03b2-boswellic acid against MCF-7 cells in vitro. J Genet Eng Biotechnol 21(1):75","journal-title":"J Genet Eng Biotechnol"},{"key":"3899_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fcell.2021.642352","volume":"9","author":"A Akil","year":"2021","unstructured":"Akil A, Guti\u00e9rrez-Garc\u00eda AK, Guenter R, Rose JB, Beck AW, Chen H, Ren B (2021) Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective. Front Cell Dev Biol 9:177","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"3899_CR5","doi-asserted-by":"publisher","first-page":"7746","DOI":"10.3390\/ijms24097746","volume":"24","author":"Y Al Salhi","year":"2023","unstructured":"Al Salhi Y, Sequi MB, Valenzi FM, Fuschi A, Martoccia A, Pietro SP, Carbone A, Tema G, Lombardo R, Cicione A (2023) Cancer stem cells and prostate cancer: a narrative review. Int J Mol Sci 24(9):7746","journal-title":"Int J Mol Sci"},{"key":"3899_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.msec.2016.05.093","volume":"68","author":"N Alam","year":"2016","unstructured":"Alam N, Qayum A, Kumar A, Khare V, Sharma PR, Andotra SS, Singh SK, Koul S, Gupta PN (2016) Improved efficacy of cisplatin in combination with a nano-formulation of pentacyclic triterpenediol. Mater Sci Eng C 68:109\u2013116","journal-title":"Mater Sci Eng C"},{"issue":"1","key":"3899_CR7","doi-asserted-by":"publisher","first-page":"19979","DOI":"10.1038\/s41598-022-24229-y","volume":"12","author":"K Alam","year":"2022","unstructured":"Alam K, Al-Riyami K, Csuk R, Arefian E, Al-Harrasi A (2022) Comparative study of the cytotoxicity, apoptotic, and epigenetic effects of Boswellic acid derivatives on breast cancer. Sci Rep 12(1):19979","journal-title":"Sci Rep"},{"key":"3899_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-020-00442-1","volume":"21","author":"S Al-Bahlani","year":"2020","unstructured":"Al-Bahlani S, Burney IA, Al-Dhahli B, Al-Kharusi S, Al-Kharousi F, Al-Kalbani A, Ahmed I (2020) Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway. BMC Pharmacol Toxicol 21:1\u201310","journal-title":"BMC Pharmacol Toxicol"},{"key":"3899_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","volume":"106","author":"L Amable","year":"2016","unstructured":"Amable L (2016) Cisplatin resistance and opportunities for precision medicine. Pharmacol Res 106:27\u201336","journal-title":"Pharmacol Res"},{"key":"3899_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1189034","volume":"2022","author":"M Ayaz","year":"2022","unstructured":"Ayaz M, Nawaz A, Ahmad S, Mosa OF, Eisa Hamdoon AA, Khalifa MA, Sadiq A, Ullah F, Wadood A, Kabra A (2022) Underlying anticancer mechanisms and synergistic combinations of phytochemicals with cancer chemotherapeutics: potential benefits and risks. J Food Qual 2022:1\u201315","journal-title":"J Food Qual"},{"issue":"1","key":"3899_CR11","first-page":"15","volume":"10","author":"HF Bahmad","year":"2022","unstructured":"Bahmad HF, Demus T, Moubarak MM, Daher D, Alvarez Moreno JC, Polit F, Lopez O, Merhe A, Abou-Kheir W, Nieder AM (2022) Overcoming drug resistance in advanced prostate cancer by drug repurposing. Med Sci 10(1):15","journal-title":"Med Sci"},{"issue":"8","key":"3899_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/1573407218666220304101139","volume":"18","author":"VG Beldar","year":"2022","unstructured":"Beldar VG, Jadhao M, Laddha K (2022) Development of a simple, rapid, and economical method for extraction and isolation of 3-O-acetyl-11-keto-\u03b2-boswellic acid from the resins of Boswellia serrata. Curr Bioact Compd 18(8):94\u2013100","journal-title":"Curr Bioact Compd"},{"key":"3899_CR13","first-page":"118688","volume":"6","author":"A Boice","year":"1867","unstructured":"Boice A (1867) Bouchier-Hayes L (2020) Targeting apoptotic caspases in cancer. Biochim Biophys Acta (BBA)-Molecular Cell Res 6:118688","journal-title":"Biochim Biophys Acta (BBA)-Molecular Cell Res"},{"issue":"4","key":"3899_CR14","first-page":"97","volume":"11","author":"A Brown","year":"2019","unstructured":"Brown A, Kumar S, Tchounwou PB (2019) Cisplatin-based chemotherapy of human cancers. J Cancer Sci Ther. 11(4):97","journal-title":"J Cancer Sci Ther."},{"issue":"14","key":"3899_CR15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1055\/s-2006-951680","volume":"72","author":"B B\u00fcchele","year":"2006","unstructured":"B\u00fcchele B, Zugmaier W, Estrada A, Genze F, Syrovets T, Paetz C, Schneider B, Simmet T (2006) Characterization of 3\u03b1-acetyl-11-keto-\u03b1-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivo. Planta Med 72(14):1285\u20131289","journal-title":"Planta Med"},{"issue":"7","key":"3899_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS (2020) Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17(7):395\u2013417","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"3899_CR17","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/pros.22811","volume":"74","author":"FLF Carvalho","year":"2014","unstructured":"Carvalho FLF, Simons BW, Eberhart CG, Berman DM (2014) Notch signaling in prostate cancer: a moving target. Prostate 74(9):933\u2013945","journal-title":"Prostate"},{"issue":"11","key":"3899_CR18","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1634\/stemcells.2005-0661","volume":"24","author":"S Chiba","year":"2006","unstructured":"Chiba S (2006) Concise review: Notch signaling in stem cell systems. Stem Cells 24(11):2437\u20132447","journal-title":"Stem Cells"},{"issue":"2","key":"3899_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"T-C Chou","year":"2010","unstructured":"Chou T-C (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70(2):440\u2013446","journal-title":"Cancer Res"},{"issue":"2","key":"3899_CR20","first-page":"301","volume":"26","author":"C Ciniglia","year":"2010","unstructured":"Ciniglia C, Pinto G, Sansone C, Pollio A (2010) Acridine orange\/ethidium bromide double staining test: a simple in-vitro assay to detect apoptosis induced by phenolic compounds in plant cells. Allelopath J 26(2):301\u2013308","journal-title":"Allelopath J"},{"issue":"12","key":"3899_CR21","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1517\/13543784.9.12.2783","volume":"9","author":"GM Cragg","year":"2000","unstructured":"Cragg GM, Newman DJ (2000) Antineoplastic agents from natural sources: achievements and future directions. Expert Opin Investig Drugs 9(12):2783\u20132797","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"3899_CR22","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/ijms23031532","volume":"23","author":"S Dasari","year":"2022","unstructured":"Dasari S, Njiki S, Mbemi A, Yedjou CG, Tchounwou PB (2022) Pharmacological effects of cisplatin combination with natural products in cancer chemotherapy. Int J Mol Sci 23(3):1532","journal-title":"Int J Mol Sci"},{"key":"3899_CR23","doi-asserted-by":"publisher","first-page":"111079","DOI":"10.1016\/j.fct.2019.111079","volume":"136","author":"NAG Dos Santos","year":"2020","unstructured":"Dos Santos NAG, Ferreira RS, Dos Santos AC (2020) Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food Chem Toxicol 136:111079","journal-title":"Food Chem Toxicol"},{"key":"3899_CR24","first-page":"2079","volume":"28","author":"K Edmunds","year":"2020","unstructured":"Edmunds K, Tuffaha H, Galv\u00e3o DA, Scuffham P, Newton RU (2020) Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review. Support Care Cancer 28:2079\u20132093","journal-title":"Support Care Cancer"},{"issue":"2","key":"3899_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21608\/bvmj.2019.14254.1042","volume":"36","author":"AE Elgendy","year":"2019","unstructured":"Elgendy AE (2019) Synergistic curative effect of boswellic acid and cisplatin against diethyl nitrosamine-induced hepatocellular carcinoma. Benha Vet Med J 36(2):256\u2013263","journal-title":"Benha Vet Med J"},{"issue":"1","key":"3899_CR26","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers3011351","volume":"3","author":"A-M Florea","year":"2011","unstructured":"Florea A-M, B\u00fcsselberg D (2011) Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel) 3(1):1351\u20131371","journal-title":"Cancers (Basel)"},{"issue":"5","key":"3899_CR27","doi-asserted-by":"publisher","first-page":"e1257","DOI":"10.1038\/cddis.2013.428","volume":"5","author":"L Galluzzi","year":"2014","unstructured":"Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G (2014) Systems biology of cisplatin resistance: past, present and future. Cell Death Dis 5(5):e1257\u2013e1257","journal-title":"Cell Death Dis"},{"issue":"3","key":"3899_CR28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3892\/ijo.2013.2223","volume":"44","author":"J Gumulec","year":"2014","unstructured":"Gumulec J, Balvan J, Sztalmachova M, Raudenska M, Dvorakova V, Knopfova L, Polanska H, Hudcova K, Ruttkay-Nedecky B, Babula P (2014) Cisplatin-resistant prostate cancer model: differences in antioxidant system, apoptosis and cell cycle. Int J Oncol 44(3):923\u2013933","journal-title":"Int J Oncol"},{"issue":"44","key":"3899_CR29","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.2174\/1381612822666160831101529","volume":"22","author":"ME Hardie","year":"2016","unstructured":"Hardie ME, Kava HW, Murray V (2016) Cisplatin analogues with an increased interaction with DNA: Prospects for therapy. Curr Pharm Des 22(44):6645\u20136664","journal-title":"Curr Pharm Des"},{"key":"3899_CR30","doi-asserted-by":"publisher","first-page":"852424","DOI":"10.3389\/fonc.2022.852424","volume":"12","author":"A Hasan","year":"2022","unstructured":"Hasan A, Rizvi SF, Parveen S, Pathak N, Nazir A, Mir SS (2022) Crosstalk between ROS and autophagy in tumorigenesis: understanding the multifaceted paradox. Front Oncol 12:852424","journal-title":"Front Oncol"},{"issue":"4","key":"3899_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.15537\/smj.2017.4.17061","volume":"38","author":"F Hassan","year":"2017","unstructured":"Hassan F, El-Hiti GA, Abd-Allateef M, Yousif E (2017) Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells. Saudi Med J 38(4):359","journal-title":"Saudi Med J"},{"issue":"9","key":"3899_CR32","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/cas.13729","volume":"109","author":"H Hongo","year":"2018","unstructured":"Hongo H, Kosaka T, Oya M (2018) Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer. Cancer Sci 109(9):2937\u20132945","journal-title":"Cancer Sci"},{"key":"3899_CR33","doi-asserted-by":"publisher","unstructured":"Hu Y-Y, Zheng M, Zhang R, Liang Y-M, Han H (2012) Notch signaling pathway and cancer metastasis. Notch Signal Embryol Cancer 186\u2013198. https:\/\/doi.org\/10.1007\/978-1-4614-0899-4_14","DOI":"10.1007\/978-1-4614-0899-4_14"},{"issue":"7899","key":"3899_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","volume":"603","author":"P Jaaks","year":"2022","unstructured":"Jaaks P, Coker EA, Vis DJ, Edwards O, Carpenter EF, Leto SM, Dwane L, Sassi F, Lightfoot H, Barthorpe S, van der Meer D, Yang W, Beck A, Mironenko T, Hall C, Hall J, Mali I, Richardson L, Tolley C, Morris J, Garnett MJ (2022) Effective drug combinations in breast, colon and pancreatic cancer cells. Nature 603(7899):166\u2013173. https:\/\/doi.org\/10.1038\/s41586-022-04437-2","journal-title":"Nature"},{"issue":"9","key":"3899_CR35","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.3390\/molecules28093746","volume":"28","author":"C Jakobu\u0161i\u0107 Brala","year":"2023","unstructured":"Jakobu\u0161i\u0107 Brala C, Karkovi\u0107 Markovi\u0107 A, Kugi\u0107 A, Tori\u0107 J, Barbari\u0107 M (2023) Combination chemotherapy with selected polyphenols in preclinical and clinical studies\u2014an update overview. Molecules 28(9):3746. https:\/\/doi.org\/10.3390\/molecules28093746","journal-title":"Molecules"},{"issue":"1","key":"3899_CR36","doi-asserted-by":"publisher","first-page":"19979","DOI":"10.1038\/s41598-022-24229-y","volume":"12","author":"F Jamshidi-Adegani","year":"2022","unstructured":"Jamshidi-Adegani F, Ghaemi S, Al-Hashmi S, Vakilian S, Al-Kindi J, Rehman NU, Alam K, Al-Riyami K, Csuk R, Arefian E, Al-Harrasi A (2022) Comparative study of the cytotoxicity, apoptotic, and epigenetic effects of boswellic acid derivatives on breast cancer. Sci Rep 12(1):19979","journal-title":"Sci Rep"},{"key":"3899_CR37","doi-asserted-by":"publisher","unstructured":"Jiang X, Liu Y, Zhang G, Lin S, Yuan N, Wu J, Yan X, Ma Y, Ma M (2020) Acetyl-11-keto-\u03b2-boswellic acid inhibits precancerous breast lesion MCF-10AT cells via regulation of LINC00707\/miR-206 that reduces estrogen receptor-\u03b1. Cancer Manag Res 2301\u20132314. https:\/\/doi.org\/10.2147\/CMAR.S238051","DOI":"10.2147\/CMAR.S238051"},{"issue":"3","key":"3899_CR38","first-page":"4493","volume":"2006","author":"S Kasibhatla","year":"2006","unstructured":"Kasibhatla S, Amarante-Mendes GP, Finucane D, Brunner T, Bossy-Wetzel E, Green DR (2006) Acridine orange\/ethidium bromide (AO\/EB) staining to detect apoptosis. Csh Protoc 2006(3):4493","journal-title":"Csh Protoc"},{"key":"3899_CR39","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3389\/fphar.2017.01002","volume":"8","author":"T Khan","year":"2018","unstructured":"Khan T, Gurav P (2018) PhytoNanotechnology: enhancing delivery of plant based anti-cancer drugs. Front Pharmacol 8:1002","journal-title":"Front Pharmacol"},{"issue":"11\u201312","key":"3899_CR40","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1080\/01635581.2020.1828942","volume":"73","author":"I Khan","year":"2021","unstructured":"Khan I, Mahfooz S, Faisal M, Alatar AA, Ansari IA (2021) Andrographolide induces apoptosis and cell cycle arrest through inhibition of aberrant hedgehog signaling pathway in colon cancer cells. Nutr Cancer 73(11\u201312):2428\u20132446","journal-title":"Nutr Cancer"},{"issue":"1","key":"3899_CR41","first-page":"5381692","volume":"2019","author":"SJ Kim","year":"2019","unstructured":"Kim SJ, Kim HS, Seo YR (2019) Understanding of ROS-inducing strategy in anticancer therapy. Oxid Med Cell Longev 2019(1):5381692","journal-title":"Oxid Med Cell Longev"},{"issue":"17","key":"3899_CR42","doi-asserted-by":"publisher","first-page":"e175217","DOI":"10.1172\/JCI175217","volume":"134","author":"SY Ku","year":"2024","unstructured":"Ku SY, Wang Y, Garcia MM, Yamada Y, Mizuno K, Long MD, Rosario S, Chinnam M, Al Assaad M, Puca L, Kim MJ, Bakht MK, Venkadakrishnan VB, Robinson BD, Acosta AM, Wadosky KM, Mosquera JM, Goodrich DW, Beltran H (2024) Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer. J Clin Investig 134(17):e175217","journal-title":"J Clin Investig"},{"key":"3899_CR43","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ejmech.2016.09.089","volume":"126","author":"K Li","year":"2017","unstructured":"Li K, Li L, Wang S, Li X, Ma T, Liu D, Jing Y, Zhao L (2017) Design and synthesis of novel 2-substituted 11-keto-boswellic acid heterocyclic derivatives as anti-prostate cancer agents with Pin1 inhibition ability. Eur J Med Chem 126:910\u2013919","journal-title":"Eur J Med Chem"},{"key":"3899_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0664-4","volume":"37","author":"W Li","year":"2018","unstructured":"Li W, Liu J, Fu W, Zheng X, Ren L, Liu S, Wang J, Ji T, Du G (2018) 3-O-acetyl-11-keto-\u03b2-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2\/M phase. J Exp Clin Cancer Res 37:1\u201315","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"3899_CR45","doi-asserted-by":"publisher","first-page":"9853","DOI":"10.1021\/acsomega.2c00203","volume":"7","author":"C Li","year":"2022","unstructured":"Li C, He Q, Xu Y, Lou H, Fan P (2022) Synthesis of 3-O-acetyl-11-keto-\u03b2-boswellic acid (AKBA)-derived amides and their mitochondria-targeted antitumor activities. ACS Omega 7(11):9853\u20139866","journal-title":"ACS Omega"},{"key":"3899_CR46","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1245\/s10434-010-1118-9","volume":"17","author":"J-T Lin","year":"2010","unstructured":"Lin J-T, Chen M-K, Yeh K-T, Chang C-S, Chang T-H, Lin C-Y, Wu Y-C, Su B-W, Lee K-D, Chang P-J (2010) Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer. Ann Surg Oncol 17:2976\u20132983","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"3899_CR47","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/bph.14816","volume":"177","author":"SR Lin","year":"2020","unstructured":"Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, Sung PJ, Chen JC, Weng CF (2020) Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. Br J Pharmacol 177(6):1409\u20131423. https:\/\/doi.org\/10.1111\/bph.14816","journal-title":"Br J Pharmacol"},{"issue":"4","key":"3899_CR48","first-page":"501","volume":"10","author":"J-J Liu","year":"2002","unstructured":"Liu J-J, Nilsson A, Oredsson S, Badmaev V, Duan R-D (2002) Keto-and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int J Mol Med 10(4):501\u2013505","journal-title":"Int J Mol Med"},{"issue":"8","key":"3899_CR49","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/sj.bjp.0706817","volume":"148","author":"J-J Liu","year":"2006","unstructured":"Liu J-J, Huang B, Hooi SC (2006) Acetyl-keto-\u03b2-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells. Br J Pharmacol 148(8):1099","journal-title":"Br J Pharmacol"},{"issue":"1","key":"3899_CR50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","volume":"32","author":"J Liu","year":"2022","unstructured":"Liu J, Peng Y, Wei W (2022) Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends Cell Biol 32(1):30\u201344","journal-title":"Trends Cell Biol"},{"issue":"4","key":"3899_CR51","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-07-2978","volume":"68","author":"M Lu","year":"2008","unstructured":"Lu M, Xia L, Hua H, Jing Y (2008) Acetyl-keto-\u03b2-boswellic acid induces apoptosis through a death receptor 5\u2013mediated pathway in prostate cancer cells. Cancer Res 68(4):1180\u20131186","journal-title":"Cancer Res"},{"key":"3899_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10565-020-09541-5","volume":"37","author":"M Lv","year":"2021","unstructured":"Lv M, Zhuang X, Zhang Q, Cheng Y, Wu D, Wang X, Qiao T (2021) Acetyl-11-keto-\u03b2-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway. Cell Biol Toxicol 37:209\u2013228","journal-title":"Cell Biol Toxicol"},{"key":"3899_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s004419900160","volume":"301","author":"G Makin","year":"2000","unstructured":"Makin G, Hickman JA (2000) Apoptosis and cancer chemotherapy. Cell Tissue Res 301:143\u2013152","journal-title":"Cell Tissue Res"},{"key":"3899_CR54","doi-asserted-by":"publisher","unstructured":"Manzari-Tavakoli A, Babajani A, Tavakoli MM, Safaeinejad F, Jafari A (2024) Integrating natural compounds and nanoparticle-based drug delivery systems: a novel strategy for enhanced efficacy and selectivity in cancer therapy. Cancer Med 13(5):e7010.\u00a0https:\/\/doi.org\/10.1002\/cam4.7010","DOI":"10.1002\/cam4.7010"},{"issue":"7","key":"3899_CR55","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrurol.2013.110","volume":"10","author":"L Marignol","year":"2013","unstructured":"Marignol L, Rivera-Figueroa K, Lynch T, Hollywood D (2013) Hypoxia, notch signalling, and prostate cancer. Nat Rev Urol 10(7):405\u2013413","journal-title":"Nat Rev Urol"},{"key":"3899_CR56","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1200\/GO.20.00122","volume":"6","author":"P Mathur","year":"2020","unstructured":"Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS (2020) Cancer statistics, 2020: report from national cancer registry programme. India JCO Glob Oncol 6:1063\u20131075","journal-title":"India JCO Glob Oncol"},{"issue":"3","key":"3899_CR57","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccr.2014.02.018","volume":"25","author":"P Ntziachristos","year":"2014","unstructured":"Ntziachristos P, Lim JS, Sage J, Aifantis I (2014) From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell 25(3):318\u2013334","journal-title":"Cancer Cell"},{"issue":"2","key":"3899_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.20892\/j.issn.2095-3941.2016.0032","volume":"14","author":"AH Nwabo Kamdje","year":"2017","unstructured":"Nwabo Kamdje AH, Takam Kamga P, Tagne Simo R, Vecchio L, Seke Etet PF, Muller JM, Bassi G, Lukong E, Kumar Goel R, Mbo AJ (2017) Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog. Cancer Biol Med 14(2):109\u2013120","journal-title":"Cancer Biol Med"},{"key":"3899_CR59","first-page":"387","volume":"5","author":"YS Park","year":"2002","unstructured":"Park YS, Lee JH, Harwalkar JA, Bondar J, Safayhi H, Golubic M (2002) Acetyl-11-Keto-\u00df-Boswellic acid (Akba) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2. Eicosanoids Other Bioact Lipids Cancer, Inflammation. Radiat Inj 5:387\u2013393","journal-title":"Radiat Inj"},{"issue":"1","key":"3899_CR60","doi-asserted-by":"publisher","first-page":"33146","DOI":"10.1038\/srep33146","volume":"6","author":"AS Pathania","year":"2016","unstructured":"Pathania AS, Guru SK, Kumar S, Kumar A, Ahmad M, Bhushan S, Sharma PR, Mahajan P, Shah BA, Sharma S (2016) Interplay between cell cycle and autophagy induced by boswellic acid analog. Sci Rep 6(1):33146","journal-title":"Sci Rep"},{"issue":"4","key":"3899_CR61","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/medicina55040110","volume":"55","author":"R Pezzani","year":"2019","unstructured":"Pezzani R, Salehi B, Vitalini S, Iriti M, Zu\u00f1iga FA, Sharifi-Rad J, Martorell M, Martins N (2019) Synergistic effects of plant derivatives and conventional chemotherapeutic agents: an update on the cancer perspective. Medicina (B Aires) 55(4):110","journal-title":"Medicina (B Aires)"},{"issue":"4","key":"3899_CR62","doi-asserted-by":"publisher","first-page":"e09103","DOI":"10.1016\/j.heliyon.2022.e09103","volume":"8","author":"A Qayum","year":"2022","unstructured":"Qayum A, Magotra A, Shah SM, Nandi U, Sharma PR, Shah BA, Singh SK (2022) Synergistic combination of PMBA and 5-fluorouracil (5-FU) in targeting mutant KRAS in 2D and 3D colorectal cancer cells. Heliyon 8(4):e09103","journal-title":"Heliyon"},{"issue":"5","key":"3899_CR63","doi-asserted-by":"publisher","first-page":"627","DOI":"10.21037\/tau-22-281","volume":"11","author":"Y Qing","year":"2022","unstructured":"Qing Y, Wang Y, Hu C, Zhang H, Huang Y, Zhang Z, Ma T, Zhang S, Li K (2022) Evaluation of NOTCH family genes\u2019 expression and prognostic value in prostate cancer. Transl Androl Urol 11(5):627\u2013642","journal-title":"Transl Androl Urol"},{"issue":"7","key":"3899_CR64","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2217\/fon.12.68","volume":"8","author":"Y Qurishi","year":"2012","unstructured":"Qurishi Y, Hamid A, Sharma PR, Wani ZA, Mondhe DM, Singh SK, Zargar MA, Andotra SS, Shah BA, Taneja SC (2012) PARP cleavage and perturbance in mitochondrial membrane potential by 3-\u03b1-propionyloxy-\u03b2-boswellic acid results in cancer cell death and tumor regression in murine models. Futur Oncol 8(7):867\u2013881","journal-title":"Futur Oncol"},{"key":"3899_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-cancerbio-041916-065808","volume":"1","author":"CR Reczek","year":"2017","unstructured":"Reczek CR, Chandel NS (2017) The two faces of reactive oxygen species in cancer. Annu Rev Cancer Biol 1:79\u201398","journal-title":"Annu Rev Cancer Biol"},{"issue":"1","key":"3899_CR66","doi-asserted-by":"publisher","first-page":"188481","DOI":"10.1016\/j.bbcan.2020.188481","volume":"1875","author":"M Rizzo","year":"2021","unstructured":"Rizzo M (2021) Mechanisms of docetaxel resistance in prostate cancer: the key role played by miRNAs. Biochim Biophys Acta (BBA)-Reviews Cancer 1875(1):188481","journal-title":"Biochim Biophys Acta (BBA)-Reviews Cancer"},{"key":"3899_CR67","doi-asserted-by":"publisher","first-page":"e478s","DOI":"10.6061\/clinics\/2018\/e478s","volume":"73","author":"CRR Rocha","year":"2018","unstructured":"Rocha CRR, Silva MM, Quinet A, Cabral-Neto JB, Menck CFM (2018) DNA repair pathways and cisplatin resistance: an intimate relationship. Clinics 73:e478s","journal-title":"Clinics"},{"issue":"14","key":"3899_CR68","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1200\/JCO.2011.40.4905","volume":"30","author":"A Rossi","year":"2012","unstructured":"Rossi A, Di Maio M, Chiodini P, Rudd RM, Okamoto H, Skarlos DV, Fr\u00fch M, Qian W, Tamura T, Samantas E (2012) Carboplatin-or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 30(14):1692\u20131698","journal-title":"J Clin Oncol"},{"issue":"1","key":"3899_CR69","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/J.CANLET.2016.04.017","volume":"377","author":"NK Roy","year":"2016","unstructured":"Roy NK, Deka A, Bordoloi D, Mishra S, Kumar AP, Sethi G, Kunnumakkara AB (2016) The potential role of boswellic acids in cancer prevention and treatment. Cancer Lett 377(1):74\u201386. https:\/\/doi.org\/10.1016\/J.CANLET.2016.04.017","journal-title":"Cancer Lett"},{"issue":"17","key":"3899_CR70","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.3390\/ijms20174101","volume":"20","author":"NK Roy","year":"2019","unstructured":"Roy NK, Parama D, Banik K, Bordoloi D, Devi AK, Thakur KK, Padmavathi G, Shakibaei M, Fan L, Sethi G (2019) An update on pharmacological potential of boswellic acids against chronic diseases. Int J Mol Sci 20(17):4101","journal-title":"Int J Mol Sci"},{"issue":"19","key":"3899_CR71","doi-asserted-by":"publisher","first-page":"6854","DOI":"10.1158\/0008-5472.CAN-04-2500","volume":"64","author":"S Santagata","year":"2004","unstructured":"Santagata S, Demichelis F, Riva A, Varambally S, Hofer MD, Kutok JL, Kim R, Tang J, Montie JE, Chinnaiyan AM (2004) JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 64(19):6854\u20136857","journal-title":"Cancer Res"},{"issue":"3","key":"3899_CR72","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1677\/ERC-10-0074","volume":"17","author":"FH Sarkar","year":"2010","unstructured":"Sarkar FH, Li Y, Wang Z, Kong D (2010) Novel targets for prostate cancer chemoprevention. Endocr Relat Cancer 17(3):R195","journal-title":"Endocr Relat Cancer"},{"issue":"4\u20135","key":"3899_CR73","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4103\/ijmr.ijmr_1821_22","volume":"156","author":"K Sathishkumar","year":"2022","unstructured":"Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P (2022) Cancer incidence estimates for 2022 & projection for 2025: result from national cancer Registry Programme, India. Indian J Med Res 156(4\u20135):598","journal-title":"Indian J Med Res"},{"issue":"2","key":"3899_CR74","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","volume":"48","author":"LA Sena","year":"2012","unstructured":"Sena LA, Chandel NS (2012) Physiological roles of mitochondrial reactive oxygen species. Mol Cell 48(2):158\u2013167","journal-title":"Mol Cell"},{"issue":"1","key":"3899_CR75","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nrclinonc.2010.136","volume":"8","author":"B Seruga","year":"2011","unstructured":"Seruga B, Ocana A, Tannock IF (2011) Drug resistance in metastatic castration-resistant prostate cancer. Nat Rev Clin Oncol 8(1):12\u201323","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"3899_CR76","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/01635581.2011.523502","volume":"63","author":"MK Shanmugam","year":"2011","unstructured":"Shanmugam MK, Kannaiyan R, Sethi G (2011) Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer 63(2):161\u2013173","journal-title":"Nutr Cancer"},{"issue":"1","key":"3899_CR77","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","volume":"9","author":"Q Shi","year":"2024","unstructured":"Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang S, Wang J, Zhang Y, Zhu D, Li L (2024) Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduct Target Ther 9(1):128","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3899_CR78","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. Ca Cancer J Clin 73(1):17\u201348","journal-title":"Ca Cancer J Clin"},{"issue":"4","key":"3899_CR79","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.bbrc.2016.09.128","volume":"479","author":"S Sobue","year":"2016","unstructured":"Sobue S, Mizutani N, Aoyama Y, Kawamoto Y, Suzuki M, Nozawa Y, Ichihara M, Murate T (2016) Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel. Biochem Biophys Res Commun 479(4):808\u2013813","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3899_CR80","first-page":"149","volume":"31","author":"Q Su","year":"2016","unstructured":"Su Q, Xin L (2016) Notch signaling in prostate cancer: refining a therapeutic opportunity. Histol Histopathol 31(2):149\u2013157","journal-title":"Histol Histopathol"},{"key":"3899_CR81","doi-asserted-by":"publisher","unstructured":"Sundaram MK, Raina R, Afroze N, Dhupkar A, Kaur NP, Arte A, Khan FA, Hussain A (2019) Combinational use of phytochemicals and chemotherapeutic drugs enhance their therapeutic potential on human cervical cancer cells. Int J Cancer Manag 12(6). https:\/\/doi.org\/10.5812\/ijcm.91783","DOI":"10.5812\/ijcm.91783"},{"issue":"7","key":"3899_CR82","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1074\/jbc.M409477200","volume":"280","author":"T Syrovets","year":"2005","unstructured":"Syrovets T, Gschwend JE, B\u00fcchele B, Laumonnier Y, Zugmaier W, Genze F, Simmet T (2005) Inhibition of I\u03baB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo. J Biol Chem 280(7):6170\u20136180","journal-title":"J Biol Chem"},{"issue":"5","key":"3899_CR83","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.4049\/jimmunol.176.5.3127","volume":"176","author":"Y Takada","year":"2006","unstructured":"Takada Y, Ichikawa H, Badmaev V, Aggarwal BB (2006) Acetyl-11-keto-\u03b2-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-\u03baB and NF-\u03baB-regulated gene expression. J Immunol 176(5):3127\u20133140","journal-title":"J Immunol"},{"issue":"17","key":"3899_CR84","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.3390\/molecules27175452","volume":"27","author":"WH Talib","year":"2022","unstructured":"Talib WH, Awajan D, Hamed RA, Azzam AO, Mahmod AI, AL-Yasari IH (2022) Combination anticancer therapies using selected phytochemicals. Molecules 27(17):5452","journal-title":"Molecules"},{"issue":"1","key":"3899_CR85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","volume":"19","author":"C Tang","year":"2023","unstructured":"Tang C, Livingston MJ, Safirstein R, Dong Z (2023) Cisplatin nephrotoxicity: new insights and therapeutic implications. Nat Rev Nephrol 19(1):53\u201372","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"3899_CR86","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3390\/pharmaceutics15041317","volume":"15","author":"PV Teixeira","year":"2023","unstructured":"Teixeira PV, Fernandes E, Soares TB, Adega F, Lopes CM, L\u00facio M (2023) Natural compounds: co-delivery strategies with chemotherapeutic agents or nucleic acids using lipid-based nanocarriers. Pharmaceutics 15(4):1317. https:\/\/doi.org\/10.3390\/pharmaceutics15041317","journal-title":"Pharmaceutics"},{"key":"3899_CR87","doi-asserted-by":"publisher","first-page":"1187181","DOI":"10.3389\/fphar.2023.1187181","volume":"14","author":"VL Trivedi","year":"2023","unstructured":"Trivedi VL, Soni R, Dhyani P, Sati P, Tejada S, Sureda A, Setzer WN, Faizal Abdull Razis A, Modu B, Butnariu M, Sharifi-Rad J (2023) Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent. Front Pharmacol 14:1187181","journal-title":"Front Pharmacol"},{"key":"3899_CR88","doi-asserted-by":"publisher","unstructured":"Trivedi A, Hasan A, Ahmad R, Siddiqui S, Srivastava A, Misra A, Mir SS. 2023. Flavonoid myricetin as potent anticancer agent: a possibility towards development of potential anticancer nutraceuticals. Chin J Integr Med 1\u201310. https:\/\/doi.org\/10.1007\/s11655-023-3701-5","DOI":"10.1007\/s11655-023-3701-5"},{"issue":"2","key":"3899_CR89","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s12033-024-01089-7","volume":"67","author":"M Verma","year":"2025","unstructured":"Verma M, Fatima S, Saeed M, Ansari IA (2025) Anti-proliferative, pro-apoptotic, and chemosensitizing potential of 3-acetyl-11-keto-\u03b2-boswellic acid (AKBA) against prostate cancer cells. Mol Biotechnol 67(2):746\u2013761","journal-title":"Mol Biotechnol"},{"issue":"7\u20138","key":"3899_CR90","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1081\/CNV-120005926","volume":"20","author":"A Vickers","year":"2002","unstructured":"Vickers A (2002) Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest 20(7\u20138):1069\u20131079","journal-title":"Cancer Invest"},{"issue":"4","key":"3899_CR91","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jcb.22451","volume":"109","author":"Z Wang","year":"2010","unstructured":"Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH (2010) Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-\u03baB signaling pathways. J Cell Biochem 109(4):726\u2013736","journal-title":"J Cell Biochem"},{"issue":"22","key":"3899_CR92","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.7150\/jca.45176","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, Wu X, Song Y, Cheng H (2020) Curcumin induces G2\/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells. J Cancer 11(22):6704","journal-title":"J Cancer"},{"issue":"3","key":"3899_CR93","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/molecules28031022","volume":"28","author":"J Wu","year":"2023","unstructured":"Wu J, Li Y, He Q, Yang X (2023) Exploration of the use of natural compounds in combination with chemotherapy drugs for tumor treatment. Molecules 28(3):1022. https:\/\/doi.org\/10.3390\/molecules28031022","journal-title":"Molecules"},{"issue":"1","key":"3899_CR94","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.yexcr.2014.08.016","volume":"328","author":"J Yan","year":"2014","unstructured":"Yan J, Tang D (2014) Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response. Exp Cell Res 328(1):132\u2013142","journal-title":"Exp Cell Res"},{"issue":"8","key":"3899_CR95","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1002\/jemt.24125","volume":"85","author":"B Yilmaz \u00d6zt\u00fcrk","year":"2022","unstructured":"Yilmaz \u00d6zt\u00fcrk B, Feyzullazade N, Da\u011f \u0130, \u015eengel T (2022) The investigation of in vitro effects of farnesol at different cancer cell lines. Microsc Res Tech 85(8):2760\u20132775","journal-title":"Microsc Res Tech"},{"issue":"22","key":"3899_CR96","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.1158\/0008-5472.CAN-11-1338","volume":"71","author":"YA Yoo","year":"2011","unstructured":"Yoo YA, Kang MH, Lee HJ, Kim B, Park JK, Kim HK, Kim JS, Oh SC (2011) Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res 71(22):7061\u20137070","journal-title":"Cancer Res"},{"key":"3899_CR97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10689-014-9757-9","volume":"14","author":"B Zhang","year":"2015","unstructured":"Zhang B, Wang D, Guo F, Xuan C (2015) Mitochondrial membrane potential and reactive oxygen species in cancer stem cells. Fam Cancer 14:19\u201323","journal-title":"Fam Cancer"},{"key":"3899_CR98","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s11101-019-09628-w","volume":"19","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li H, Zhang J, Zhao C, Lu S, Qiao J, Han M (2020) The combinatory effects of natural products and chemotherapy drugs and their mechanisms in breast cancer treatment. Phytochem Rev 19:1179\u20131197","journal-title":"Phytochem Rev"},{"issue":"1","key":"3899_CR99","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","volume":"7","author":"B Zhou","year":"2022","unstructured":"Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K, Chu Q (2022) Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther 7(1):95","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3899_CR100","first-page":"368","volume":"5","author":"H Zhu","year":"2013","unstructured":"Zhu H, Zhou X, Redfield S, Lewin J, Miele L (2013) Elevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancers. Am J Transl Res 5(3):368","journal-title":"Am J Transl Res"},{"issue":"1","key":"3899_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12645-020-00074-4","volume":"12","author":"Z Zibaei","year":"2021","unstructured":"Zibaei Z, Babaei E, Rezaie Nezhad Zamani A, Rahbarghazi R, Azeez HJ (2021) Curcumin-enriched Gemini surfactant nanoparticles exhibited tumoricidal effects on human 3D spheroid HT-29 cells in vitro. Cancer Nanotechnol 12(1):1\u201315","journal-title":"Cancer Nanotechnol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03899-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-03899-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03899-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:44:52Z","timestamp":1757144692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-03899-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":101,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3899"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-03899-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}